The current institutional shareholding score of Pliant Therapeutics Inc is 7.00, ranking 50 out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 81.81%, representing a quarter-over-quarter decrease of 4.56%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.99% of shares outstanding, with 0.08% decrease in holdings.